Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply | Annals of Internal Medicine

Moderna and Pfizer have both submitted data to FDA that allows a clear projection that one dose of vaccine produces 80-90% efficacy. This has been thoroughly reviewed in UK and Germany which is why they are considering allowing a 6 month interval to get 2nd dose. Source: Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply | Annals of Internal Medicine